Germline mutation of MDM4 , a major p53 regulator, in a familial syndrome of defective telomere maintenance
Open Access
- 10 April 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (15), eaay3511
- https://doi.org/10.1126/sciadv.aay3511
Abstract
Dyskeratosis congenita is a cancer-prone inherited bone marrow failure syndrome caused by telomere dysfunction. A mouse model recently suggested that p53 regulates telomere metabolism, but the clinical relevance of this finding remained uncertain. Here, a germline missense mutation of MDM4, a negative regulator of p53, was found in a family with features suggestive of dyskeratosis congenita, e.g., bone marrow hypocellularity, short telomeres, tongue squamous cell carcinoma, and acute myeloid leukemia. Using a mouse model, we show that this mutation (p.T454M) leads to increased p53 activity, decreased telomere length, and bone marrow failure. Variations in p53 activity markedly altered the phenotype of Mdm4 mutant mice, suggesting an explanation for the variable expressivity of disease symptoms in the family. Our data indicate that a germline activation of the p53 pathway may cause telomere dysfunction and point to polymorphisms affecting this pathway as potential genetic modifiers of telomere biology and bone marrow function.Funding Information
- NIH Clinical Center
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Nationale Contre le Cancer
- Gefluc
This publication has 55 references indexed in Scilit:
- Beginning at the ends: telomeres and human diseaseF1000Research, 2018
- Essential role for centromeric factors following p53 loss and oncogenic transformationPublished by Cold Spring Harbor Laboratory ,2017
- p53 downregulates the Fanconi anaemia DNA repair pathwayNature Communications, 2016
- Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activityOncogene, 2014
- An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and ChemosensitivityCancer Research, 2010
- Deconstructing nucleotide binding activity of the Mdm2 RING domainNucleic Acids Research, 2010
- Flow cytometry and FISH to measure the average length of telomeres (flow FISH)Nature Protocols, 2006
- Inactivation of the p53 pathway in retinoblastomaNature, 2006
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989